Quality of Life in Hypoparathyroidism

• Autores: Tamara J. Vokes
• Localización: Endocrinology and metabolism clinics of North America, ISSN 0889-8529, Vol. 47, Nº. 4, 2018 (Ejemplar dedicado a: Hypoparathyroidism), págs. 855-864
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Patients with hypoparathyroidism have a multitude of physical, emotional, and cognitive complaints consistent with reduced quality of life (QOL). Impaired QOL in patients treated with conventional therapy with calcium and active vitamin D has been documented in epidemiologic (registry) studies, case-controlled studies, and surveys, and at baseline in clinical trials of parathyroid hormone (PTH). Treatment with PTH has been shown to improve QOL in some but not all studies.